Wednesday, July 8, 2026

Patent directory · USPTO A61K / A61P

Patents matching “SION”

1,496 pharma patents match "SION" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 1,496
Index total 30,257
Page 44 / 63

Quick answer

This filtered view shows 1,496 pharmaceutical patents matching "SION" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

1,496 results for “SION” · 30,257 patents in full index Clear search

  1. US 8680113

    BMI-1 protein expression modulators

    PTC THERAPEUTICS, INC. · Granted Mar 25, 2014 · Expires Mar 20, 2034

    granted
  2. US 8664193

    Compositions and methods for inhibiting expression of factor VII gene

    Alnylam Pharmaceuticals, Inc. · Granted Mar 4, 2014 · Expires Feb 27, 2034

    granted
  3. US 8658356

    Methods and compositions for the specific inhibition of gene expression by double-stranded RNA

    INTEGRATED DNA TECHNOLOGIES, INC. · Granted Feb 25, 2014 · Expires Feb 20, 2034

    granted
  4. US 8658778

    hTMC promoter and vectors for the tumor-selective and high-efficient expression of cancer therapeutic genes

    The Board of Regents of the University of Texas System · Granted Feb 25, 2014 · Expires Feb 20, 2034

    granted
  5. US 8652443

    Foamable microemulsion compositions for topical administration

    Precision Dermatology, Inc. · Granted Feb 18, 2014 · Expires Feb 13, 2034

    granted
  6. US 8647842

    Methods for producing a fusion protein capable of binding VEGF

    REGENERON PHARMACEUTICALS, INC. · Granted Feb 11, 2014 · Expires Feb 6, 2034

    granted
  7. US 8648100

    Roflumilast for the treatment of pulmonary hypertension

    TAKEDA GMBH · Granted Feb 11, 2014 · Expires Feb 6, 2034

    granted
  8. US 8633034

    Methods for evaluating the aggregation of a protein in a suspension including organopolysiloxane and medical articles coated with organopolysiloxane containing a protein solution

    The Regents of the University of Colorado · Granted Jan 21, 2014 · Expires Jan 16, 2034

    granted
  9. US 8632751

    Scanning suspension comprising a particle with a diameter of at least 1 micrometer

    Universitair Medisch Centrum Utrecht · Granted Jan 21, 2014 · Expires Jan 16, 2034

    granted
  10. US 8623330

    Emollient foams for treatment of seborrheic dermatitis

    Precision Dermatology, Inc. · Granted Jan 7, 2014 · Expires Jan 2, 2034

    granted
  11. US 8617557

    Antibody fusion with IL-12 proteins with disrupted heparin-binding activity

    The Regents of the University of California · Granted Dec 31, 2013 · Expires Dec 26, 2033

    granted
  12. US 8614198

    Hepatitis C dsRNA effector molecules, expression constructs, compositions, and methods of use

    Alnylam Pharmaceuticals, Inc. · Granted Dec 24, 2013 · Expires Dec 19, 2033

    granted
  13. US 8609728

    Treatment for pulmonary hypertension

    United Therapeutics Corporation · Granted Dec 17, 2013 · Expires Dec 12, 2033

    granted
  14. US 8609067

    Method of measuring propulsion in lymphatic structures

    The Board of Regents of the University of Texas System · Granted Dec 17, 2013 · Expires Dec 12, 2033

    granted
  15. US 8597655

    Recombinant fusion protein and polynucleotide construct for immunotoxin production

    The Medical Research, Infrastructure and Health Services Fund of the Tel-Aviv Medical Center · Granted Dec 3, 2013 · Expires Nov 28, 2033

    granted
  16. US 8598316

    Molecules that selectively home to vasculature of pre-malignant dysplastic lesions or malignancies

    The Regents of the University of California · Granted Dec 3, 2013 · Expires Nov 28, 2033

    granted
  17. US 8597898

    Fusion polypeptides capable of activating receptors

    REGENERON PHARMACEUTICALS, INC. · Granted Dec 3, 2013 · Expires Nov 28, 2033

    granted
  18. US 8592380

    Aerosol foams comprising clindamycin phosphate

    Precision Dermatology, Inc. · Granted Nov 26, 2013 · Expires Nov 21, 2033

    granted
  19. US 8592570

    Compositions and methods for inhibiting expression of an RNA from West Nile virus

    Alnylam Pharmaceuticals, Inc. · Granted Nov 26, 2013 · Expires Nov 21, 2033

    granted
  20. WO 2013169458

    COMPOSITIONS PHARMACEUTIQUES ET MÉTHODES DE TRAITEMENT, DE CONTRÔLE, D'AMÉLIORATION, OU D'INVERSION DES TROUBLES DE LA KÉRATOCONJONCTIVITE SÈCHE

    BAUSCH & LOMB [US] · Granted Nov 14, 2013 · Expires Nov 9, 2033

    granted
  21. US 8580738

    Methods for treatment of reperfusion injury and other cardiac conditions

    The Board of Regents of the University of Texas System · Granted Nov 12, 2013 · Expires Nov 7, 2033

    granted
  22. US 8580936

    Polynucleotides encoding FGFR1-IIIc ECD fusion proteins

    Five Prime Therapeutics, Inc. · Granted Nov 12, 2013 · Expires Nov 7, 2033

    granted
  23. US 8574653

    Intermittent flow extrusion process and food product

    Del Monte Corporation · Granted Nov 5, 2013 · Expires Oct 31, 2033

    granted
  24. US 8563692

    Interferon-antibody fusion proteins demonstrating potent apoptotic and anti-tumor activities

    The Regents of the University of California · Granted Oct 22, 2013 · Expires Oct 17, 2033

    granted